CR002 Liquid API
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
CSL Behring
Overview
CR002 Liquid API is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
CR002 Liquid API clinical trials
Explore related
Medical disclaimer. This page summarizes research about CR002 Liquid API for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.